Erratum: Two engineered site-specific antibody-drug conjugates, HLmD4 and HLvM4, have potent therapeutic activity in two DLL4-positive tumour xenograft models

Am J Cancer Res. 2022 Jun 15;12(6):2893-2896. eCollection 2022.

Authors

Shijing Wang¹, Hui Wen¹, Wenyi Fei¹, Yuhong Zhao¹, Yuqi Feng¹, Lu Kuang¹, Min Wang¹, Min Wu¹

Affiliation

¹ State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University Nanjing 210009, China.

PMID: 35812052
PMCID: PMC9251689

Abstract

[This corrects the article on p. 2387 in vol. 10, PMID: 32905508.].

AJCR Copyright © 2022.

Publication types

Published Erratum